RU2018129984A - Пробиотики и способы их применения - Google Patents
Пробиотики и способы их применения Download PDFInfo
- Publication number
- RU2018129984A RU2018129984A RU2018129984A RU2018129984A RU2018129984A RU 2018129984 A RU2018129984 A RU 2018129984A RU 2018129984 A RU2018129984 A RU 2018129984A RU 2018129984 A RU2018129984 A RU 2018129984A RU 2018129984 A RU2018129984 A RU 2018129984A
- Authority
- RU
- Russia
- Prior art keywords
- specified
- child
- composition
- bacterium
- birth
- Prior art date
Links
- 239000006041 probiotic Substances 0.000 title claims 9
- 235000018291 probiotics Nutrition 0.000 title claims 9
- 241000894006 Bacteria Species 0.000 claims 17
- 241001135265 Cronobacter sakazakii Species 0.000 claims 8
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 claims 8
- 230000000529 probiotic effect Effects 0.000 claims 8
- 208000035143 Bacterial infection Diseases 0.000 claims 4
- 241000588724 Escherichia coli Species 0.000 claims 4
- 241000186605 Lactobacillus paracasei Species 0.000 claims 4
- 241000186779 Listeria monocytogenes Species 0.000 claims 4
- 241000588650 Neisseria meningitidis Species 0.000 claims 4
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 4
- 208000022362 bacterial infectious disease Diseases 0.000 claims 4
- 239000003937 drug carrier Substances 0.000 claims 4
- 235000013305 food Nutrition 0.000 claims 4
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 4
- 239000012228 culture supernatant Substances 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/02—Making cheese curd
- A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Pediatric Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Claims (38)
1. Способ лечения бактериальной инфекции у ребенка, включающий пероральное введение эффективного количества композиции, содержащей пробиотическую бактерию Lactobacillus paracasei CBA L74, регистрационный номер в международном депозитарии LMG Р-24778, матери указанного ребенка.
2. Способ по п. 1, в котором композицию вводят указанной матери до рождения указанного ребенка.
3. Способ по п. 1, в котором композицию вводят указанной матери после рождения указанного ребенка.
4. Способ по п. 1, в котором композицию вводят указанной матери до рождения указанного ребенка и после рождения указанного ребенка.
5. Способ по п. 1, в котором пробиотическая бактерия является нереплицируемой.
6. Способ по п. 1, в котором бактерия представляет собой Salmonella typhimurium, Cronobacter sakazakii, Escherichia coli, Listeria monocytogenes, Streptococcus pneumoniae, или Neisseria meningitidis.
7. Способ по п. 1, в котором бактерия представляет собой Salmonella typhimurium FB62.
8. Способ по п. 1, в котором бактерия представляет собой Cronobacter sakazakii.
9. Способ по п. 1, в котором композиция содержит пищевой продукт или фармацевтический носитель.
10. Способ по п. 1, в котором композицию вводят до тех пор, пока симптом инфекции не улучшится.
11. Способ профилактики или уменьшения тяжести бактериальной инфекции у ребенка, включающий пероральное введение эффективного количества композиции, содержащей пробиотическую бактерию Lactobacillus paracasei CBA L74, регистрационный номер в международном депозитарии LMG Р-24778, матери указанного ребенка.
12. Способ по п. 11, в котором композицию вводят указанной матери до рождения указанного ребенка.
13. Способ по п. 11, в котором композицию вводят указанной матери после рождения указанного ребенка.
14. Способ по п. 11, в котором композицию вводят указанной матери до рождения указанного ребенка и после рождения указанного ребенка.
15. Способ по п. 11, в котором пробиотическая бактерия является нереплицируемой.
16. Способ по п. 11, в котором бактерия представляет собой Salmonella typhimurium, Cronobacter sakazakii, Escherichia coli, Listeria monocytogenes, Streptococcus pneumoniae, или Neisseria meningitidis.
17. Способ по п. 16, в котором бактерия представляет собой Salmonella typhimurium FB62.
18. Способ по п. 16, в котором бактерия представляет собой Cronobacter sakazakii.
19. Способ по п. 11, в котором композиция содержит пищевой продукт или фармацевтический носитель.
20. Способ лечения бактериальной инфекции у ребенка, включающий пероральное введение эффективного количества композиции, содержащей культуральный супернатант клеток пробиотических бактерий Lactobacillus paracasei CBA L74, регистрационный номер в международном депозитарии LMG Р-24778, матери указанного ребенка.
21. Способ по п. 20, в котором композицию вводят указанной матери до рождения указанного ребенка.
22. Способ по п. 20, в котором композицию вводят указанной матери после рождения указанного ребенка.
23. Способ по п. 20, в котором композицию вводят указанной матери до рождения указанного ребенка и после рождения указанного ребенка.
24. Способ по п. 20, в котором пробиотическая бактерия является нереплицируемой.
25. Способ по п. 20, в котором бактерия представляет собой Salmonella typhimurium, Cronobacter sakazakii, Escherichia coli, Listeria monocytogenes, Streptococcus pneumoniae, или Neisseria meningitidis.
26. Способ по п. 25, в котором бактерия представляет собой Salmonella typhimurium FB62.
27. Способ по п. 25, в котором бактерия представляет собой Cronobacter sakazakii.
28. Способ по п. 20, в котором композиция содержит пищевой продукт или фармацевтический носитель.
29. Способ по п. 20, в котором композицию вводят до тех пор, пока симптом инфекции не улучшится.
30. Способ профилактики или уменьшения тяжести бактериальной инфекции у ребенка, включающий пероральное введение эффективного количества композиции, содержащей культуральный супернатант клеток пробиотических бактерий Lactobacillus paracasei CBA L74, регистрационный номер в международном депозитарии LMG Р-24778, матери указанного ребенка.
31. Способ по п. 30, в котором композицию вводят указанной матери до рождения указанного ребенка.
32. Способ по п. 30, в котором композицию вводят указанной матери после рождения указанного ребенка.
33. Способ по п. 30, в котором композицию вводят указанной матери до рождения указанного ребенка и после рождения указанного ребенка.
34. Способ по п. 30, в котором пробиотическая бактерия является нереплицируемой.
35. Способ по п. 30, в котором бактерия представляет собой Salmonella typhimurium, Cronobacter sakazakii, Escherichia coli, Listeria monocytogenes, Streptococcus pneumoniae, или Neisseria meningitidis.
36. Способ по п. 35, в котором бактерия представляет собой Salmonella typhimurium FB62.
37. Способ по п. 35, в котором бактерия представляет собой Cronobacter sakazakii.
38. Способ по п. 30, в котором композиция содержит пищевой продукт или фармацевтический носитель.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361821990P | 2013-05-10 | 2013-05-10 | |
| US61/821,990 | 2013-05-10 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015150082A Division RU2665637C2 (ru) | 2013-05-10 | 2014-05-09 | Способ получения пробиотиков и способы их применения |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2023128481A Division RU2023128481A (ru) | 2023-11-02 | Пробиотики и способы их применения |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2018129984A true RU2018129984A (ru) | 2019-03-15 |
| RU2018129984A3 RU2018129984A3 (ru) | 2022-04-06 |
Family
ID=51867774
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015150082A RU2665637C2 (ru) | 2013-05-10 | 2014-05-09 | Способ получения пробиотиков и способы их применения |
| RU2018129984A RU2018129984A (ru) | 2013-05-10 | 2014-05-09 | Пробиотики и способы их применения |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015150082A RU2665637C2 (ru) | 2013-05-10 | 2014-05-09 | Способ получения пробиотиков и способы их применения |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US9980991B2 (ru) |
| EP (2) | EP3470074B1 (ru) |
| CN (2) | CN105209050B (ru) |
| AU (2) | AU2014262453B2 (ru) |
| BR (1) | BR112015028164B1 (ru) |
| CA (1) | CA2911496C (ru) |
| DK (2) | DK3470074T3 (ru) |
| ES (2) | ES2729641T3 (ru) |
| MX (2) | MX370692B (ru) |
| NZ (1) | NZ714202A (ru) |
| PL (2) | PL2994150T3 (ru) |
| PT (2) | PT2994150T (ru) |
| RU (2) | RU2665637C2 (ru) |
| TR (1) | TR201908066T4 (ru) |
| WO (1) | WO2014183050A1 (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2734049T3 (en) | 2011-06-20 | 2018-07-30 | Heinz Co Brands H J Llc | PROBIOTIC COMPOSITIONS AND PROCEDURES |
| TR201814973T4 (tr) | 2012-06-18 | 2018-11-21 | Heinz Co Brands H J Llc | Gluten ile ilgili bozukluklar. |
| US9980991B2 (en) | 2013-05-10 | 2018-05-29 | H.J. Heinz Company Brands Llc | Probiotics and methods of use |
| WO2019149940A1 (en) * | 2018-02-02 | 2019-08-08 | Postbiotica S.R.L. | Use of a postbiotic-based composition for the treatment of skin diseases |
| MX2021007599A (es) * | 2018-12-19 | 2021-10-13 | Healthy Cow Corp | Composiciones probióticas listas para utilizar y usos de las mismas. |
| CN110305821B (zh) * | 2019-08-28 | 2019-12-17 | 鲁东大学 | 副干酪乳杆菌配合car-t细胞治疗应用 |
| US11638726B2 (en) | 2019-09-25 | 2023-05-02 | Tall Goods Llc | Methods for producing probiotics fortified avian eggs and egg products and formulations thereof |
| KR102637723B1 (ko) * | 2023-08-09 | 2024-02-19 | 이대훈 | 배변 기능 개선용 조성물 및 이를 포함하는 반려동물용 영양제 |
Family Cites Families (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1025140A (en) | 1905-02-16 | 1912-05-07 | Otis Elevator Co | Potential switch. |
| US1025865A (en) | 1910-10-13 | 1912-05-07 | Hampden Watch Company | Balance staff and roller for watches. |
| US1003929A (en) | 1911-04-04 | 1911-09-19 | Jacob T Lutz | Trace-carrier. |
| US1024530A (en) | 1911-08-02 | 1912-04-30 | John Elmer Smith | Watchmaker's tool. |
| EP0130228A1 (en) | 1983-07-01 | 1985-01-09 | Microlife Technics, Inc. | Fermentation method using a selected lactobacillus |
| RU2134583C1 (ru) * | 1996-02-29 | 1999-08-20 | Санкт-Петербургская государственная педиатрическая медицинская академия | Способ санации женщин с массивной микробной обсемененностью грудного молока |
| AU3173497A (en) | 1996-06-21 | 1998-01-14 | Quest International B.V. | Fermentation of fruit products |
| SE510813C2 (sv) | 1997-12-08 | 1999-06-28 | Arla Ekonomisk Foerening | Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen |
| EP1034787A1 (en) * | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactobacillus strains preventing diarrhea caused by pathogenic bacteria |
| SE522747C2 (sv) | 1999-11-18 | 2004-03-02 | Probi Ab | Barnmatsprodukt |
| FI110668B (fi) * | 2000-06-20 | 2003-03-14 | Aboatech Ab Oy | Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn |
| SE0003100D0 (sv) | 2000-09-01 | 2000-09-01 | Probi Ab | New strains |
| GB0027761D0 (en) | 2000-11-14 | 2000-12-27 | Nestle Sa | Nutritional composition for an immune condition |
| KR100419132B1 (ko) | 2000-12-29 | 2004-02-18 | 조성근 | 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01 |
| EP2364718B1 (en) | 2002-02-14 | 2016-07-06 | The Board of Trustees of the Leland Stanford Junior University | Enzyme treatment of foodstuffs for celiac sprue |
| EP1364586A1 (en) | 2002-05-24 | 2003-11-26 | Nestec S.A. | Probiotics and oral tolerance |
| ATE402993T1 (de) * | 2002-06-28 | 2008-08-15 | Puleva Biotech Sa | Probiotische stämme, verfahren zur ihren selektion, diese enthaltende zusammensetzungen und ihre verwendung |
| BRPI0415480B1 (pt) | 2003-10-16 | 2019-09-17 | Nestec S.A. | Composição nutricional contra efeitos colaterais de quimioterapia ou radioterapia |
| DK1675481T3 (da) | 2003-10-24 | 2009-01-19 | Nutricia Nv | Synbiotisk præparat til börn |
| US7955834B2 (en) * | 2004-06-03 | 2011-06-07 | Biogaia Ab | Method for improved breast milk feeding to reduce the risk of allergy |
| EP1723951A1 (en) | 2005-04-21 | 2006-11-22 | N.V. Nutricia | Nutritional supplement with oligosaccharides for a category of HIV patients |
| US7862808B2 (en) | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
| DE602004006258T3 (de) | 2004-08-24 | 2013-08-29 | Nutricia N.V. | Nahrungszusammensetzung die unverdauliche Transgalaktooligosaccharide sowie verdauliche Galaktose-Saccharide enthält |
| US20060194241A1 (en) | 2005-02-28 | 2006-08-31 | Jan Knol | Lactobacillus specific probes |
| BRPI0608782A2 (pt) | 2005-04-13 | 2010-01-26 | Nestec Sa | fórmula para bebê com probióticos |
| US20060233772A1 (en) | 2005-04-15 | 2006-10-19 | Udo Herz | Method for preventing or treating the development of respiratory allergies |
| EP1714660A1 (en) | 2005-04-21 | 2006-10-25 | N.V. Nutricia | Uronic acid and probiotics |
| US8075934B2 (en) | 2008-10-24 | 2011-12-13 | Mead Johnson Nutrition Company | Nutritional composition with improved digestibility |
| RU2423879C2 (ru) | 2005-07-01 | 2011-07-20 | Н.В. Нютрисиа | Детское питание с гидролизованными белками |
| EP1970366A4 (en) | 2005-12-08 | 2010-07-28 | Kirin Holdings Kk | CLATCH OF AN ISOHUMULIN COMPOUND AND COMPOSITION THAT CONTAINS THIS |
| DE602006019941D1 (de) | 2006-03-27 | 2011-03-17 | Nestec Sa | Im Proteingehalt angereichertes gefrorenes Dessert |
| WO2007140622A1 (en) | 2006-06-09 | 2007-12-13 | Nutravital Inc. | Dairy-derived probiotic compositions and uses thereof |
| PT1893033E (pt) | 2006-07-07 | 2008-12-02 | Alpro Nv | Método para preparar um análogo de um produto lácteo |
| EP1974743A1 (en) | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics to Improve Gut Microbiota |
| WO2008153377A1 (en) | 2007-06-15 | 2008-12-18 | N.V. Nutricia | Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
| WO2009067000A1 (en) | 2007-11-20 | 2009-05-28 | N.V. Nutricia | Composition with synbiotics |
| CN101451158A (zh) | 2007-12-04 | 2009-06-10 | 黑龙江大学 | 副干酪乳杆菌产生的抗菌肽的分离纯化方法 |
| EP2110027A1 (en) * | 2008-04-01 | 2009-10-21 | Nestec S.A. | Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation |
| RU2010153257A (ru) * | 2008-05-27 | 2012-07-10 | Нестек С.А. (Ch) | Пробиотики для улудшения микробиоты пищеварительного тракта |
| WO2009151315A1 (en) | 2008-06-13 | 2009-12-17 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
| EP2138187A1 (en) | 2008-06-24 | 2009-12-30 | Nestec S.A. | Probiotics, secretory IgA and infection |
| WO2010002241A1 (en) | 2008-06-30 | 2010-01-07 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
| WO2010008272A1 (en) | 2008-07-15 | 2010-01-21 | N.V. Nutricia | Treatment of gut motility disorders |
| EP2147678A1 (en) | 2008-07-21 | 2010-01-27 | Nestec S.A. | Probiotics to increase IgA secretion in infants born by caesarean section |
| RU2011115184A (ru) | 2008-09-19 | 2012-10-27 | Нестек С.А. (Ch) | Питательная поддержка для предупреждения или ослабления паралича костного мозга или нейтропении во время противораковой терапии |
| EP2168444A1 (en) | 2008-09-24 | 2010-03-31 | Nestec S.A. | Acidified nutritional formula |
| AU2009319257B2 (en) | 2008-11-03 | 2014-10-09 | Société des Produits Nestlé S.A. | A nutritional composition comprising probiotics and improving sleep patterns |
| EP2452574A1 (en) | 2010-11-15 | 2012-05-16 | Nestec S.A. | Age-tailored nutritional formula with particularly adapted caloric density for young infants |
| MX2011004921A (es) | 2008-12-08 | 2011-05-30 | Nestec Sa | Modulacion de la grasa corporal infantil. |
| US20100196341A1 (en) * | 2009-02-05 | 2010-08-05 | Syngen Biotech Co., Ltd. | Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof |
| EP2413952B2 (en) | 2009-04-03 | 2019-10-02 | Société des Produits Nestlé S.A. | Improvement in promotion of healthy catch-up growth |
| ES2382263T3 (es) | 2009-05-11 | 2012-06-06 | Nestec S.A. | Prevención y tratamiento de la diarrea alérgica |
| JP5860396B2 (ja) | 2009-05-11 | 2016-02-16 | ネステク ソシエテ アノニム | ラクトバチルス・ジョンソニーＬａ１ＮＣＣ５３３（ＣＮＣＭＩ−１２２５）及び免疫障害 |
| WO2010143940A1 (en) | 2009-06-12 | 2010-12-16 | N.V. Nutricia | Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages |
| US20110070334A1 (en) | 2009-09-20 | 2011-03-24 | Nagendra Rangavajla | Probiotic Stabilization |
| EP2308498A1 (en) | 2009-09-30 | 2011-04-13 | Nestec S.A. | Administration of Bifidobacterium breve during infancy to prevent inflammation later in life |
| EA031179B1 (ru) | 2010-03-12 | 2018-11-30 | Компани Жервэ Данон | Молочнокислые бактерии, применяемые при чревной болезни |
| WO2011121379A1 (en) | 2010-03-30 | 2011-10-06 | Assistance Publique - Hopitaux De Paris | Use of bifidobacteria for preventing allergy in breastfed infants |
| WO2011149335A1 (en) | 2010-05-25 | 2011-12-01 | N.V. Nutricia | Immune imprinting nutritional composition |
| US20110293784A1 (en) | 2010-05-28 | 2011-12-01 | Anja Wittke | Milk-based nutritional compositions |
| WO2011148221A1 (en) | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Lactic acid bacteria for maturation of the enteric nervous system in infants |
| CN102021127B (zh) | 2010-07-28 | 2012-05-30 | 江南大学 | 一株副干酪乳杆菌及其应用 |
| EP2449890A1 (en) | 2010-11-05 | 2012-05-09 | Nestec S.A. | Powdered cereal compositions comprising non-replicating probiotic microorganisms |
| EP2449891A1 (en) | 2010-11-05 | 2012-05-09 | Nestec S.A. | Drinking yoghurt preparations containing non-replicating probiotic micro-organisms |
| EP2455094A1 (en) | 2010-11-11 | 2012-05-23 | Nestec S.A. | Non-replicating probiotic micro-organisms protect children against gastrointestinal infections |
| EP2452572A1 (en) | 2010-11-15 | 2012-05-16 | Nestec S.A. | Age-tailored nutritional formula with particularly adapted caloric density for infants and children |
| RU2600877C2 (ru) | 2010-12-06 | 2016-10-27 | Н.В. Нютрисиа | Ферментированное детское питание |
| EP2510932A1 (en) * | 2011-04-15 | 2012-10-17 | Nestec S.A. | Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny |
| DK2734049T3 (en) * | 2011-06-20 | 2018-07-30 | Heinz Co Brands H J Llc | PROBIOTIC COMPOSITIONS AND PROCEDURES |
| EP2761691A4 (en) | 2011-09-28 | 2015-04-22 | Phillips 66 Co | COMPOSITE SOLID OXYGEN FUEL ELECTROLYTE |
| TR201814973T4 (tr) | 2012-06-18 | 2018-11-21 | Heinz Co Brands H J Llc | Gluten ile ilgili bozukluklar. |
| US9980991B2 (en) | 2013-05-10 | 2018-05-29 | H.J. Heinz Company Brands Llc | Probiotics and methods of use |
-
2014
- 2014-05-09 US US14/890,026 patent/US9980991B2/en active Active
- 2014-05-09 CN CN201480026882.7A patent/CN105209050B/zh active Active
- 2014-05-09 CN CN201910988302.7A patent/CN110651824A/zh active Pending
- 2014-05-09 PL PL14795405T patent/PL2994150T3/pl unknown
- 2014-05-09 PT PT14795405T patent/PT2994150T/pt unknown
- 2014-05-09 EP EP18209662.8A patent/EP3470074B1/en active Active
- 2014-05-09 PT PT182096628T patent/PT3470074T/pt unknown
- 2014-05-09 AU AU2014262453A patent/AU2014262453B2/en active Active
- 2014-05-09 RU RU2015150082A patent/RU2665637C2/ru active
- 2014-05-09 DK DK18209662.8T patent/DK3470074T3/da active
- 2014-05-09 ES ES14795405T patent/ES2729641T3/es active Active
- 2014-05-09 WO PCT/US2014/037517 patent/WO2014183050A1/en not_active Ceased
- 2014-05-09 MX MX2015015515A patent/MX370692B/es active IP Right Grant
- 2014-05-09 BR BR112015028164-8A patent/BR112015028164B1/pt active IP Right Grant
- 2014-05-09 PL PL18209662T patent/PL3470074T3/pl unknown
- 2014-05-09 NZ NZ714202A patent/NZ714202A/en unknown
- 2014-05-09 EP EP14795405.1A patent/EP2994150B1/en active Active
- 2014-05-09 CA CA2911496A patent/CA2911496C/en active Active
- 2014-05-09 ES ES18209662T patent/ES2837384T3/es active Active
- 2014-05-09 RU RU2018129984A patent/RU2018129984A/ru unknown
- 2014-05-09 TR TR2019/08066T patent/TR201908066T4/tr unknown
- 2014-05-09 DK DK14795405.1T patent/DK2994150T3/da active
-
2015
- 2015-11-09 MX MX2019015306A patent/MX2019015306A/es unknown
-
2016
- 2016-11-16 US US15/352,994 patent/US10258656B2/en active Active
-
2018
- 2018-05-25 US US15/989,878 patent/US10729733B2/en active Active
-
2019
- 2019-09-02 AU AU2019226131A patent/AU2019226131B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2018129984A (ru) | Пробиотики и способы их применения | |
| JP2016529309A5 (ru) | ||
| RU2498605C2 (ru) | Питательная композиция для грудных детей, рожденных с проведением кесарева сечения | |
| BR132020021160E2 (pt) | composição compreendendo um fermentado de bactéria probiótica lactobacillus paracasei cba l74 e uso do mesmo | |
| Chassard et al. | Probiotics tailored to the infant: a window of opportunity | |
| Rad | Can probiotics prevent or improve common cold and influenza? | |
| Snelling | Effects of probiotics on the gastrointestinal tract | |
| AR076862A1 (es) | Microorganismos no replicantes y su efecto de refuerzo inmunologico. composicion. metodo para aumentar efectividad de probioticos | |
| Kafshdooz et al. | Role of probiotics in managing of Helicobacter pylori infection: A review | |
| JP2014073130A5 (ru) | ||
| ME02941B (me) | Sojevi bakterija koji su izolovani iz svinja | |
| Chingwaru et al. | Potential of Zimbabwean commercial probiotic products and strains of Lactobacillus plantarum as prophylaxis and therapy against diarrhoea caused by Escherichia coli in children | |
| PH12015501845A1 (en) | Low-buffer nutritional compositions and uses thereof | |
| Weizman | The role of probiotics and prebiotics in the prevention of infections in child day-care centres | |
| RU2017122615A (ru) | Применение пробиотиков для усиления мужской фертильности | |
| JP2015533484A5 (ru) | ||
| John et al. | Otitis media among high-risk populations: can probiotics inhibit Streptococcus pneumoniae colonisation and the risk of disease? | |
| Guarner et al. | World Gastroenterology Organisation practice guideline: probiotics and prebiotics-May 2008: guideline | |
| WO2011133681A3 (en) | Low/high dose probiotic supplements and methods of their use | |
| RU2010136972A (ru) | Новое применение пробиотиков | |
| Mancuskova et al. | The medical functions of probiotics and their role in clinical nutrition | |
| RU2023128481A (ru) | Пробиотики и способы их применения | |
| JP2014516248A5 (ru) | ||
| AR071905A1 (es) | Metodo para reducir borborigmos mediante la administracion de una bacteria bifidobacterium | |
| Goli et al. | Efficacy of probiotics as an adjuvant agent in eradication of Helicobacter pylori infection and associated side effects |